Drug labels are not specific enough, according to the American Academyof Pediatrics, which has now recommended mandatory labeling of inactive ingredients on prescription and over-the-counter products.
"The voluntary system is clearly inadequate," said the Academy in a report in the journal Pediatrics. Companies are not now required to disclose inactive ingredients on the labels of drugs taken orally; the AAP notes that these substances are rarely named because manufacturers want to preserve trade secrets.
However, inactive ingredients such as sweeteners and dyes can trigger breathing problems, seizures and diarrhea, the report said; the last two plus bronchospasms are the most common adverse reactions in children. A recent survey of 102 chewable and liquid pediatric drugs found that 90% reported on the label that a sweetener was included, but few provided the specific sweetener ingredients, said the report.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze